@subhamadhavan

Precision Medicine & Digital Health Leader, Data scientist, Great boss award, Force multiplier, Service to America award, Startup & NonProfit Board Governance

 Georgetown University
icbi.georgetown.edu/page.php?ID=Madhavan
Joined October 2009
  • Tweets1.8K
  • Following999
  • Followers1.1K
213Media
#ASCO22 excited to reconnect with these two amazing breast cancer leaders @DrLauraEsserman @claudine_isaacs
1
6
Super excited about this panel with @TClozel @NCIJBSloan Jim Chen and @ihuerga at #BioIT22 next week. Join us in person or virtually to discuss how #AI is transforming #oncology R&D and care delivery. bio-itworldexpo.com/
2
8
Leading experts discuss applications, pitfalls, and future directions for applications of AI in oncology in the AI for Oncology, Precision Medicine, and Health track @ Bio-IT this May! bio-itworldexpo.com/?utm_med… #BioIT22 @bioitworld #medicine #research #health #ai @subhamadhavan
2
2
Thrilled to see this work on standardized evidence for evaluating NTRK fusions in patients published with amazing co-authors #precisiononcology #DataScience #evidencebasedmedicine
Alanna Church, MD@AlannaChurch_MD31 Mar 2022
Important features when evaluating a potentially oncogenic fusion like LMNA-NTRK1: ✅stranding and directionality ✅ kinase domain preserved ✅ in-frame sciencedirect.com/science/ar…
3
#DigitalHealth COVID-19 Impact Assessment: Lessons Learned and Compelling Needs In @theNAMedicine by @peteratmsr, @dramyabernethy , @DShaywitz, Adi Gundlapalli, Jim Weinstein, P. Murali Doraiswamy, @kevin_schulman, & @subhamadhavan nam.edu/digital-health-covid…
2
6
Invited Speaker @subhamadhavan presented incredibly innovative work at #CGCAnnual2021 using #AI, #NLP, and expert crowdsourcing approaches to enable precision medicine, match patients to trials, automatically identify adverse events, and standardize curation of somatic variants.
2
8
Presentation by @DespinaKontos from @PennMedicine at #ASCO21 where her team applies #machinelearning to radiomics, clinical and molecular features to develop treatment plans for cancer patients. New approaches with #datascience #digitalhealth for #cancercare
4
1
5
Terrific graphic that highlights differences between lung and breast clinical communities in terms of uptake of precision medicines. #ASCO21’s theme of access to (right) care is clearly important. – at Travilah, MD
Stephen V Liu, MD
@StephenVLiu6 Jun 2021
Thought provoking graphic. I would say that despite initial (healthy) debate, most of us in the lung cancer space are recommending adjuvant osimertinib where available. #LCSM #ASCO21
4
Subha Madhavan retweeted
Gerson Rolim@GersonRolim4 May 2021
The future of Clinical Trials: how #AI, #BigTech, & #Covid19 could make drug development cheaper, faster & more effective #DX #ML V/@CBinsights @GersonRolim @intellimetri cbinsights.com/research/clin… #100DaysOfCode #WomenWhoCode #100DaysOfMLCode #HealthTech #Coding #Chatbot #Python
24
16
Congratulations to @Georgetown_HIDS alumni Fuyuan Wang! He recently joined @FredNatLab subcontractor Essential Software as Software Engineer. Apply to our one year industry driven #HealthInformatics & #DataScience Masters Program. Deadline July 1st: lnkd.in/ejrdtg6
2
2
Subha Madhavan retweeted
Mark Hoffman@markhoffmankc15 Apr 2021
Great #Nexusinformatics talk by @subhamadhavan describing virtual molecular tumor board.
2
7
Loving the first keynote from @subhamadhavan of @ICBI_Georgetown on Virtual Molecular Tumor Boards at the #NexusInformatics Conference with @BioNexusKC @ChildrensMercy @clevelandunivkc @KansasCityU
2
5
Thrilled to see this collaboration between @TheACMG, @ClinGenResource Somatic Clinical domain working group and @GA4GH @cancervariants to launch a new molecular tumor board series! #CME credit available.
ACMG
@TheACMG22 Mar 2021
Don’t miss the ClinGen Somatic Cancer/VICC Virtual Molecular Tumor Board Case Series, kicking off tomorrow, Tuesday, March 23, 2021 at 11 AM ET. Participation and CME for this new monthly series are FREE. Register now at acmgeducation.net #cancergenetics #hereditarycancer
3
8
If your work is in clinical genomics, dont miss this conference. A terrific lineup of speakers - all in a convenient virtual program.
This Post is from an account that no longer exists. Learn more
1
2
Great training opportunity in #Cancerinformatics #clinicalgenomics. Apply today to work with @HandlerWagner and a terrific team at @nationwidekids!
Alex H. Wagner@HandlerWagner21 Feb 2021
Are you (or someone you know) thinking about postdoctoral opportunities? Interested in genomic medicine and biomedical informatics research? We have an opening! Help us interpret genomes to treat childhood cancers @nationwidekids. Learn more: go.osu.edu/wagner-postdoc Please RT!
3
Subha Madhavan retweeted
Nature Cancer@NatureCancer11 Feb 2021
🌟"Envisioning the future of precision oncology trials" by @subhamadhavan &Co @NatureCancer Find it at: go.nature.com/3cLhNb5 #11F #WomenInScience #WomenAndGirlsInScience @UN_Women
1
4
Thanks Mark! It was a terrific workshop by @genome_gov to address #clinicalinformatics for #genomicmedicine. – at Travilah, MD
Mark Hoffman@markhoffmankc10 Feb 2021
Great talk by @subhamadhavan about Virtual Molecular Tumor board @gumedcenter presented to #GenomicMedicine2021 @genome_gov
1
2
It was an honor to work with this amazing team of authors to develop recommendations for design, development and implementation of adaptive clinical decision support systems. These are relevant to colleagues developing and/or deploying #digitalhealth solutions.
AMIA@AMIAinformatics8 Feb 2021
Interested in #CDS and #AI in healthcare? Read the position paper featuring authors @jefferyrlsmith, @SurvivorshipIT, @RobertFreimuth, @gpurcelljackson, @deansittig, @adamatw, @hongfangliu, @subhamadhavan and more. Available in #JAMIA and open-access! ow.ly/GphD50Dunuk

Recommendations for the safe, effective use of adaptive CDS in the US healthcare system: an AMIA...

Abstract. The development and implementation of clinical decision support (CDS) that trains itself and adapts its algorithms based on new data—here referre

academic.oup.com
5
Subha Madhavan retweeted
Mike Pishvaian
@MPishvaian3 Feb 2021
Replying to @heatherahannon @pashtoonkasi @TumorBoardTues @ASCO @NEJM @TheLancet @NTRKers
Yes, molecular tumor boards can add significant value at many levels #TumorBoardTuesday Sorry for the shameless self plug @subhamadhavan @edikb @Perthera JAMIA Open. 2019 Oct 7;2(4):505-515. doi: 10.1093/jamiaopen/ooz045. eCollection 2019 Dec.
4
5
Join us for an amazing lineup of speakers and groundbreaking research in #clinicalgenomics #precisiononcology #polygenicriskscores and much more on a virtual podium! Abstracts are due by March 16.
This Post is from an account that no longer exists. Learn more
Load more